Is a complete IPSC research report available?

No complete published report is available for Century Therapeutics, Inc. (IPSC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Century Therapeutics, Inc. (IPSC)

NASDAQ: IPSC · USD

$1.50

+0.04 (+3.1%)· Recorded snapshot

Market cap	270.7M
Net income (ttm)	-109.8M
EPS (ttm)	-$0.77
Shares out	181.1M
Volume	748,004
Beta	1.67

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -109.8M
EPS (ttm): -$0.77
Market cap: 270.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001850119
Company name	Century Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	15673T100
Earnings date	2026-11-12
Earnings time	bmo
Employees	78
Employees change	-72
Employees growth	-48%
Enterprise value	$189.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2019
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2021-06-18
Is primary listing	Yes
Is SPAC	No
ISIN number	US15673T1007
Last 10-K release date	2026-03-12
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$270.7M
Market cap category	Micro-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$1.50
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	IPSC
U.S. state	Pennsylvania
Website	https://www.centurytx.com

Metric

Value

Amount currency

USD

CIK code

0001850119

Company name

Century Therapeutics, Inc.

Country

United States

Country code

CUSIP number

15673T100

Earnings date

2026-11-12

Earnings time

bmo

Employees

Employees change

-72

Employees growth

-48%

Enterprise value

$189.7M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2019

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2021-06-18

Is primary listing

Yes

Is SPAC

ISIN number

US15673T1007

Last 10-K release date

2026-03-12

Last earnings date

2026-08-12

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$270.7M

Market cap category

Micro-Cap

Next earnings date

2026-11-12

Options

Yes

Price

$1.50

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

IPSC

U.S. state

Pennsylvania

Website

https://www.centurytx.com

Metric	Value
Earnings yield	-51.24%
FCF / EV yield	-46.67%
FCF yield	-32.65%
P/B ratio	1.13x
Price / tangible book value	1.36x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-51.24%

FCF / EV yield

-46.67%

FCF yield

-32.65%

P/B ratio

1.13x

Price / tangible book value

1.36x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-1.4M
ROA	-23.51%
ROA (5Y)	-16.79%
ROCE	-39.54%
ROE	-49.65%
ROE (5Y)	-42.69%
ROIC	-25.24%

Metric

Value

Profit per employee

$-1.4M

ROA

-23.51%

ROA (5Y)

-16.79%

ROCE

-39.54%

ROE

-49.65%

ROE (5Y)

-42.69%

ROIC

-25.24%

Metric	Value
EPS growth quarters	1
EPS growth years	2
Net income growth years	2
Revenue growth	1,556.76%
Revenue growth years	2

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth

1,556.76%

Revenue growth years

Metric	Value
Capital expenditures	$-1.3M
Depreciation and amortization	$12.3M
EBIT	$-107.5M
EBITDA	$-95.2M
EPS	$-0.77
FCF per share	$-0.49
Financing cash flow	$127M
Free cash flow	$-88.1M
Free cash flow minus SBC	$-93.7M
Gross profit	$-78.9M
Income taxes	$-68,000
Investing cash flow	$-47.8M
Net cash flow	$-7.6M
Net income	$-109.8M
Operating cash flow minus SBC	$-92.3M
Operating income	$-107.5M
Stock-based compensation	$5.6M

Metric

Value

Capital expenditures

$-1.3M

Depreciation and amortization

$12.3M

EBIT

$-107.5M

EBITDA

$-95.2M

EPS

$-0.77

FCF per share

$-0.49

Financing cash flow

$127M

Free cash flow

$-88.1M

Free cash flow minus SBC

$-93.7M

Gross profit

$-78.9M

Income taxes

$-68,000

Investing cash flow

$-47.8M

Net cash flow

$-7.6M

Net income

$-109.8M

Operating cash flow minus SBC

$-92.3M

Operating income

$-107.5M

Stock-based compensation

$5.6M

Metric	Value
Altman Z-Score	-2.69
Book value per share	$1.29
Debt / equity	0.17
Long-term assets	$162.2M
Long-term liabilities	$39.6M
Net cash (debt)	$81M
Net cash / market cap	30.04%
Net cash growth	-22.34%
Net debt / equity	-0.35
Piotroski F-Score	1
Property, plant and equipment	$48M
Shareholders' equity	$232.3M
Tangible book value	$198.1M
Tangible book value per share	$1.10
Total assets	$287M
Total cash	$119.7M
Total debt	$38.7M
Total liabilities	$54.7M
WACC	11.77%

Metric

Value

Altman Z-Score

-2.69

Book value per share

$1.29

Debt / equity

0.17

Long-term assets

$162.2M

Long-term liabilities

$39.6M

Net cash (debt)

$81M

Net cash / market cap

30.04%

Net cash growth

-22.34%

Net debt / equity

-0.35

Piotroski F-Score

Property, plant and equipment

$48M

Shareholders' equity

$232.3M

Tangible book value

$198.1M

Tangible book value per share

$1.10

Total assets

$287M

Total cash

$119.7M

Total debt

$38.7M

Total liabilities

$54.7M

WACC

11.77%

Metric	Value
Current assets	$124.8M
Current liabilities	$15.1M
Current ratio	8.28
Net working capital	$-6M
Quick ratio	8.04
Working capital	$109.7M

Metric

Value

Current assets

$124.8M

Current liabilities

$15.1M

Current ratio

8.28

Net working capital

$-6M

Quick ratio

8.04

Working capital

$109.7M

Metric	Value
Buyback yield / dilution	-67.4%
Dividend yield	0%
Shareholder yield	-67.4%

Metric

Value

Buyback yield / dilution

-67.4%

Dividend yield

Shareholder yield

-67.4%

Metric	Value
150-day SMA	$2.07
1D price change	3.1%
1M price change	-11.68%
1M total return	-11.68%
1W price change	-10.06%
1W total return	-10.06%
1Y price change	145.79%
1Y return CAGR	145.94%
1Y total return	145.79%
20-day SMA	$1.47
200-day SMA	$2.10
3M price change	-29.43%
3M total return	-29.43%
3Y price change	3.15%
3Y return CAGR	1.04%
3Y total return	3.15%
50-day SMA	$1.76
50-day SMA vs 200-day SMA	50under200
52-week high	$3.04
52-week high date	2026-03-10
52-week low	$0.44
52-week low date	2025-11-17
5Y price change	-92.98%
5Y return CAGR	-41.22%
5Y total return	-92.98%
6M price change	-34.44%
6M total return	-34.44%
All-time high	$32.90
All-time high date	2021-08-17
All-time low	$0.34
All-time low date	2025-04-09
Average true range (ATR)	$0.13
Average volume	1M
Beta (1Y)	2.5
Beta (2Y)	1.76
Beta (5Y)	1.67
Change from 52-week high	-50.82%
Change from 52-week low	243.68%
Change from all-time high	-95.52%
Change from all-time low	331.54%
Change from open	-0.33%
Day's gap	3.45%
Dollar volume	$1.1M
High price	$1.50
Low price	$1.43
Monthly RSI	38.58
Open price	$1.50
Position in 52-week range	92.86%
Previous close	$1.45
Price vs 150-day SMA	-28.71%
Price vs 20-day SMA	0.61%
Price vs 200-day SMA	-29.83%
Price vs 50-day SMA	-16.24%
Relative volume	0.75
Return from IPO open	-92.36%
Return from IPO price	-92.55%
RSI	44.6
Sharpe ratio	1.32
Sharpe ratio (3Y)	0.39
Sharpe ratio (5Y)	-0.28
Sortino ratio	2.53
Sortino ratio (3Y)	0.74
Sortino ratio (5Y)	-0.36
Volume	748K
Weekly RSI	38.6
YTD price change	48.27%
YTD total return	48.27%

Metric

Value

150-day SMA

$2.07

1D price change

3.1%

1M price change

-11.68%

1M total return

-11.68%

1W price change

-10.06%

1W total return

-10.06%

1Y price change

145.79%

1Y return CAGR

145.94%

1Y total return

145.79%

20-day SMA

$1.47

200-day SMA

$2.10

3M price change

-29.43%

3M total return

-29.43%

3Y price change

3.15%

3Y return CAGR

1.04%

3Y total return

3.15%

50-day SMA

$1.76

50-day SMA vs 200-day SMA

50under200

52-week high

$3.04

52-week high date

2026-03-10

52-week low

$0.44

52-week low date

2025-11-17

5Y price change

-92.98%

5Y return CAGR

-41.22%

5Y total return

-92.98%

6M price change

-34.44%

6M total return

-34.44%

All-time high

$32.90

All-time high date

2021-08-17

All-time low

$0.34

All-time low date

2025-04-09

Average true range (ATR)

$0.13

Average volume

Beta (1Y)

2.5

Beta (2Y)

1.76

Beta (5Y)

1.67

Change from 52-week high

-50.82%

Change from 52-week low

243.68%

Change from all-time high

-95.52%

Change from all-time low

331.54%

Change from open

-0.33%

Day's gap

3.45%

Dollar volume

$1.1M

High price

$1.50

Low price

$1.43

Monthly RSI

38.58

Open price

$1.50

Position in 52-week range

92.86%

Previous close

$1.45

Price vs 150-day SMA

-28.71%

Price vs 20-day SMA

0.61%

Price vs 200-day SMA

-29.83%

Price vs 50-day SMA

-16.24%

Relative volume

0.75

Return from IPO open

-92.36%

Return from IPO price

-92.55%

RSI

44.6

Sharpe ratio

1.32

Sharpe ratio (3Y)

0.39

Sharpe ratio (5Y)

-0.28

Sortino ratio

2.53

Sortino ratio (3Y)

0.74

Sortino ratio (5Y)

-0.36

Volume

748K

Weekly RSI

38.6

YTD price change

48.27%

YTD total return

48.27%

Metric	Value
Float	101.3M
Float percentage	55.92%
Shares change (QoQ)	6.36%
Shares change (YoY)	67.4%
Shares held by insiders	1.69%
Shares held by institutions	55.9%
Shares outstanding	181.1M
Short % of float	28.77%
Short % of shares	16.09%
Short ratio	61 days

Metric

Value

Float

101.3M

Float percentage

55.92%

Shares change (QoQ)

6.36%

Shares change (YoY)

67.4%

Shares held by insiders

1.69%

Shares held by institutions

55.9%

Shares outstanding

181.1M

Short % of float

28.77%

Short % of shares

16.09%

Short ratio

61 days

Century Therapeutics, Inc. (IPSC)

Price

Financial snapshot

Fair-value bridge

Latest news · IPSC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IPSC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on IPSC

Frequently asked questions